| Issuer | % of Class | Filed |
|---|---|---|
|
Tvardi Therapeutics, Inc.
13G/A
Amendment 1
CARA · 140755208
|
3.4% |
8/5/2025
Event 7/7/2025
|
|
Tvardi Therapeutics, Inc.
13G
CARA · 140755208
|
10.1% |
5/2/2025
Event 4/15/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.